Summary
Bengaluru-based deeptech startup Dognosis is developing a technology that combines trained dogs and AI to detect cancer from breath samples, aiming to create a standardized and affordable screening tool. The company, founded in 2024, has raised approximately $2 million in seed funding and reported around 90% accuracy in early trials, though results are not yet peer-reviewed.